Lead Pharma Holding BV

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Teams With Precision On DMD, Gene

“The Pink Sheet” regularly provides coverage of noteworthy biopharmaceutical business deals. Here is a roundup of the most significant deals that occurred between Feb. 20-26. Bristol/Flexus & Bristol

IN VITRO DIAGNOSTICS Mergers & Acquisitions Novigenix SA Diagnoplex SA Novigenix SA acquired fellow private Swiss molecular diagnostics firm Diagnoplex SA , and now has full control of the Col

Just one week after Sanofi entered the ROR gamma T inhibitor drug discovery and development space, AstraZeneca PLC found its way in by signing an exclusive option agreement with Orca Pharmac